Tommy Fornander

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Tommy Fornander

Jul 20, 2024, 17:44 | Insight

Piotr Wysocki: Who should not get dose-dense adjuvant chemotherapy in breast cancer?

Piotr Wysocki recently posted on LinkedIn: "For many years, dose-dense adjuvant chemotherapy has been considered the…

Jul 20, 2024, 10:37 | Blog

Personalized Dose-Dense Adjuvant Chemotherapy for High-Risk Early breast cancer

Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…

Jul 19, 2024, 13:20 | Blog

Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer

Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…

All: 3 Posts: 1 - 100

'

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

'

Who From Oncology is Featured in TIME100 Health 2025?

'

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

'

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023